WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2015> 26> 1

Volume: 26 Issue: 1

1. Are we ready for conservative treatment in ovarian cancer?. Page:75—76
2. Asian Society of Gynecologic Oncology International Workshop 2014. Page:68—74
3. Single-site robotic surgery in gynecologic cancer: a pilot study. Page:62—67
4. Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study. Page:54—61
5. Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings. Page:46—53
6. DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers. Page:40—45
7. Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria. Page:32—39
8. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers. Page:25—31
9. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry. Page:19—24
10. Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort. Page:12—18
11. Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors. Page:3—11
12. Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?. Page:1—2